Balyasny Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,694
| Closed | -$113K | – | 2512 |
|
|
2025
Q1 | $113K | Buy |
+24,694
| New | +$113K | ﹤0.01% | 1898 |
|
|
2023
Q4 | – | Sell |
-157,153
| Closed | -$679K | – | 2306 |
|
|
2023
Q3 | $679K | Buy |
157,153
+146,864
| +1,427% | +$634K | ﹤0.01% | 1234 |
|
|
2023
Q2 | $67.8K | Buy |
+10,289
| New | +$67.8K | ﹤0.01% | 1730 |
|
|
2023
Q1 | – | Sell |
-40,088
| Closed | -$296K | – | 2676 |
|
|
2022
Q4 | $296K | Buy |
40,088
+29,970
| +296% | +$221K | ﹤0.01% | 1567 |
|
|
2022
Q3 | $100K | Buy |
+10,118
| New | +$100K | ﹤0.01% | 1921 |
|
|
2019
Q3 | – | Sell |
-20,197
| Closed | -$285K | – | 1450 |
|
|
2019
Q2 | $285K | Buy |
+20,197
| New | +$285K | ﹤0.01% | 1192 |
|
|
2018
Q2 | – | Sell |
-24,617
| Closed | -$415K | – | 1934 |
|
|
2018
Q1 | $415K | Buy |
24,617
+14,117
| +134% | +$238K | ﹤0.01% | 1315 |
|
|
2017
Q4 | $160K | Sell |
10,500
-11,400
| -52% | -$174K | ﹤0.01% | 1691 |
|
|
2017
Q3 | $392K | Buy |
+21,900
| New | +$392K | ﹤0.01% | 1225 |
|
|
2016
Q2 | – | Sell |
-25,600
| Closed | -$214K | – | 1251 |
|
|
2016
Q1 | $214K | Sell |
25,600
-12,860
| -33% | -$108K | ﹤0.01% | 908 |
|
|
2015
Q4 | $358K | Buy |
38,460
+5,260
| +16% | +$49K | ﹤0.01% | 783 |
|
|
2015
Q3 | $374K | Buy |
33,200
+22,100
| +199% | +$249K | ﹤0.01% | 700 |
|
|
2015
Q2 | $141K | Buy |
+11,100
| New | +$141K | ﹤0.01% | 817 |
|
|
2014
Q2 | – | Sell |
-225,480
| Closed | -$3.66M | – | 586 |
|
|
2014
Q1 | $3.66M | Buy |
+225,480
| New | +$3.66M | 0.04% | 318 |
|
|
2013
Q3 | – | Sell |
-105,000
| Closed | -$848K | – | 568 |
|
|
2013
Q2 | $848K | Buy |
+105,000
| New | +$848K | 0.01% | 372 |
|